These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4358 related articles for article (PubMed ID: 6940183)

  • 21. Monoclonal antibodies that prevent adhesion of B 16 melanoma cells and reduce metastases in mice: crossreaction with human tumor cells.
    Vollmers HP; Birchmeier W
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6863-7. PubMed ID: 6316331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncontrolled nuclear division in normal x transformed somatic cell hybrids.
    Hickey I; McConville C; McMenamin M; Shirodaria P
    Br J Cancer Suppl; 1988 Dec; 9():89-92. PubMed ID: 2855469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of normal human p53 in established fibroblasts leads to their tumorigenic conversion.
    Tuck SP; Crawford L
    Oncogene Res; 1989; 4(2):81-96. PubMed ID: 2654816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant lymphoma antigen expressed in nude mouse tumor cells derived from carcinogen-transformed Bloom's syndrome B-lymphoblastoid cell lines.
    Shiraishi Y; Moriki T; Hara H; Araki K; Kozuru M; Sandberg AA
    Cancer Res; 1990 May; 50(10):3106-12. PubMed ID: 2185881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of estradiol and degree of cell differentiation on human melanoma susceptibility to killing by monoclonal antibodies.
    Hakim AA
    Immunol Lett; 1982 Jan; 4(1):59-64. PubMed ID: 7061114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transformation-related antigens identified by monoclonal antibodies.
    Strand M
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3234-8. PubMed ID: 6932018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restriction point control of cell growth by a labile protein: evidence for increased stability in transformed cells.
    Campisi J; Medrano EE; Morreo G; Pardee AB
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):436-40. PubMed ID: 6952194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency.
    Tiemann F; Deppert W
    Oncogene; 1994 Jul; 9(7):1907-15. PubMed ID: 8208537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse monoclonal antibody (WI-MN-1) against malignant melanoma.
    Khan A; Grammer S; Chang D; Hill NO; Miller J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5868-72. PubMed ID: 6196109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique proliferation-associated marker expressed on activated and transformed human cells defined by monoclonal antibody.
    Dubey DP; Staunton DE; Parekh AC; Schwarting GA; Antoniou D; Lazarus H; Yunis EJ
    J Natl Cancer Inst; 1987 Feb; 78(2):203-12. PubMed ID: 3543453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced synthesis and stabilization of Mr 68,000 protein in transformed BALB/c-3T3 cells: candidate for restriction point control of cell growth.
    Croy RG; Pardee AB
    Proc Natl Acad Sci U S A; 1983 Aug; 80(15):4699-703. PubMed ID: 6308643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression.
    Steinmeyer K; Maacke H; Deppert W
    Oncogene; 1990 Nov; 5(11):1691-9. PubMed ID: 2267135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells.
    Guo XJ; Chambers AF; Parfett CL; Waterhouse P; Murphy LC; Reid RE; Craig AM; Edwards DR; Denhardt DT
    Cell Growth Differ; 1990 Jul; 1(7):333-8. PubMed ID: 2177633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transformation by simian virus 40 induces virus-specific, related antigens in the surface membrane and nuclear envelope.
    Lin PS; Schmidt-Ullrich R; Wallach DF
    Proc Natl Acad Sci U S A; 1977 Jun; 74(6):2495-9. PubMed ID: 196291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opposed arsenite-mediated regulation of p53-survivin is involved in neoplastic transformation, DNA damage, or apoptosis in human keratinocytes.
    Li Y; Jiang R; Zhao Y; Xu Y; Ling M; Pang Y; Shen L; Zhou Y; Zhang J; Zhou J; Wang X; Liu Q
    Toxicology; 2012 Oct; 300(3):121-31. PubMed ID: 22706169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylation of p53 in primary, immortalised and transformed Balb/c mouse cells.
    Patschinsky T; Deppert W
    Oncogene; 1990 Jul; 5(7):1071-6. PubMed ID: 2142761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies.
    Levy R; Dilley J; Fox RI; Warnke R
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6552-6. PubMed ID: 316541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 in polyoma virus transformed REF52 cells.
    Mor O; Read M; Fried M
    Oncogene; 1997 Dec; 15(25):3113-9. PubMed ID: 9444959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 218.